Remote Assessment of Negative Symptoms of Schizophrenia
David G. Daniel, Stephen R. Marder(West Los Angeles College), Christopher R Brodie(Otsuka (United States)), Alex S. Cohen(Louisiana State University), Michael Davidson(Sheba Medical Center), Alan Kott, Raeanne C. Moore(University of California San Diego), William Z. Potter(National Heart Lung and Blood Institute), Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), Nina R. Schooler(SUNY Downstate Health Sciences University), Larry Alphs(Pfizer (United States)), P.D. Harvey(University of Miami), Pierre Lindenmeyer(Nathan Kline Institute for Psychiatric Research)
Cited by 16
Related Papers
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program
|American Journal of Psychiatry|2015|849
<p>Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment</p>
|Neuropsychiatric Disease and Treatment|2020|832
Self-report measures of medication adherence behavior: recommendations on optimal use
|Translational Behavioral Medicine|2015|832
Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis
|JAMA Psychiatry|2018|796